This study explores candidate metrics for use in a vendor-neutral Quality Control (QC) protocol for dual energy based (‘spectral’) contrast-enhanced digital mammography (DE-CEDM). The physical metrics were chosen for their anticipated link with clinical image quality. An extra criterion was that limiting values can be applied to these metrics. The following DE-CEDM characteristics were tested: (1) signal produced by test object inserts versus their iodine concentration for different breast tissue thicknesses and compositions, the possibility of iodine quantification and iodine detectability thresholds; (2) normal breast tissue cancellation for different types of simulated tissue compositions; (3) artefacts; (4) image uniformity; (5) exposure time and (6) mean glandular dose (MGD). The tests employed custom made and commercially available phantoms based on breast-tissue equivalent materials and iodine inserts. Initial test results on a specific DE-CEDM application (SenoBright HD, GE Healthcare) found a linear response to iodine concentration that was largely independent of background composition, with slopes in the range of 30 – 43 for iodine pixel value as a function of iodine concentration, making absolute iodine quantification possible. The residual signal due to normal tissue in the subtracted image was equivalent to less than 0.3 mg/cm2 of iodine. Artefacts were quantified and considered acceptable. For a 5 cm thick breast, the system operates at a total MGD of 1.92 mGy with a total exposure time of 4.25 s. The preliminary QC test results are ready for discussion in the broader community of radiologists, medical physicists and manufacturers.
|